Acute lymphoblastic leukemia cells are sensitive to L-asparaginase treatment because of their poor ability to synthesize sufficient amounts of endogenous L-Asn due to low expression levels of L-asparagine synthetase (ASNS) [34]. This evidence concerns the gene ASNS and acute lymphoblastic leukemia.